QUINVAXEM
Generic name not specified · by NOVARTIS
Composition
Inj: Per 0.5 ml: Absorbed diphtheria toxoid not less than 30 IU, tetanus toxoid not less than 40 IU, Absorbed pertussis toxoid 25 mcg, Absorbed filamentous haemagglutinin (FHA) 25 mcg, adsorb
Indications & Dosage
Active immunization against diphtheria, tetanus, pertussis, Haemophilus influenzae type B: BY DEEP SC OR IM INJ: Children 2 month-4 yr: 3 separate injections each of 0.5 ml at interval of minimum of 4 weeks; not recommended above 4 years age.
Contraindications
History of convulsions, cerebral irritation or damage in the neonatal period, acute illness, severe local or general reaction to a preceding dose, neurological disease.
Precautions
History of familial epilepsy. Children with history of severe local reaction to a preceding dose should be given DPT in one limb and Hib in another.
Side Effects
Fever, irritability, persistent crying, headache, loss of appetite, malaise, local pain, somnolence, allergy, neurological effects